PTEN in Colorectal Cancer: Shedding Light on Its Role as Predictor and Target
Molecular assessment of colorectal cancer (CRC) is receiving growing attention, beyond RAS and BRAF, because of its influence on prognosis and prediction in cancer treatment. PTEN (phosphatase and tensin homologue), a tumor suppressor, regulating cell division and apoptosis, has been explored, and s...
Main Authors: | Lisa Salvatore, Maria Alessandra Calegari, Fotios Loupakis, Matteo Fassan, Brunella Di Stefano, Maria Bensi, Emilio Bria, Giampaolo Tortora |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-11-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/11/11/1765 |
Similar Items
-
The Novel Phosphatase Domain Mutations Q171R and Y65S Switch PTEN from Tumor Suppressor to Oncogene
by: Jose Antonio Ma. G. Garrido, et al.
Published: (2021-12-01) -
Targeted Therapy in the Palliative Setting of Colorectal Cancer—Survival and Medical Costs
by: Kamuran Inci, et al.
Published: (2023-06-01) -
Revising PTEN in the Era of Immunotherapy: New Perspectives for an Old Story
by: Geny Piro, et al.
Published: (2019-10-01) -
Functions and regulation of the PTEN gene in colorectal cancer
by: Francesca eMolinari, et al.
Published: (2014-01-01) -
Cinobufagin Is a Selective Anti-Cancer Agent against Tumors with EGFR Amplification and PTEN Deletion
by: Kunyan He, et al.
Published: (2021-11-01)